Bayer Stock Forecast for 2022 - 2025 - 2030

Updated on 09/27/2022

Stock Rating
7
Price Target
79.50€
Consensus
Outperform
Upside
64.36%
Analysts
14
Stock Rating
7
Upside
64.36%
Analysts
14
Price Target
79.50€

Bayer Stock Forecast and Price Target

According to fourteen esteemed experts, the average price target for Bayer to reach this year is 79.50€, with a potential upside of approximately 64.36%. This prediction is based on a high estimate of 106.00€ and a low estimate of 37.06€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.

79.50€

64.36% Upside

Outperform
Outperform

Bayer Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Price has grown by 9.60%, rising from 57.62€ to 63.15€. For next year, analysts predict Fair Value of 73.82€, which would mean an increase of 16.90%. Over the next nine years, experts predict that Bayer's Fair Value will grow at a rate of 2.76%.

2022 Fair Value Forecast
73.82€
2023 Fair Value Forecast
78.67€
2024 Fair Value Forecast
82.64€
2025 Fair Value Forecast
86.14€
2026 Fair Value Forecast
83.52€
2027 Fair Value Forecast
70.33€
2028 Fair Value Forecast
67.32€
2029 Fair Value Forecast
65.67€
2030 Fair Value Forecast
64.89€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABBV Stock Forecast AbbVie Outperform 9
$141.21 Buy/Sell $164.23 10.47%
COST Stock Forecast Costco Wholesale Outperform 13
$480.30 Buy/Sell $565.43 17.11%
DHR Stock Forecast Danaher Outperform 16
$262.66 Buy/Sell $321.60 23.73%
ABT Stock Forecast Abbott Laboratories Outperform 14
$99.84 Buy/Sell $128.88 26.20%
AZN Stock Forecast AstraZeneca PLC Outperform 18
£99.33 Buy/Sell £136.08 43.33%

Bayer Revenue Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Revenue has grown by 19.97%, rising from 36.74€B to 44.08€B. For next year, analysts predict Revenue of 48.75€B, which would mean an increase of 10.59%. Over the next nine years, experts predict that Bayer's Revenue will grow at a rate of 16.35%.

2022 Rev Forecast
48.75€B
2023 Rev Forecast
49.37€B
2024 Rev Forecast
50.31€B
2025 Rev Forecast
50.64€B
2026 Rev Forecast
50.39€B
2027 Rev Forecast
50.17€B
2028 Rev Forecast
50.09€B
2029 Rev Forecast
50.75€B
2030 Rev Forecast
51.29€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Outperform 2
$70.15 Buy/Sell $79.05 18.32%
AMGN Stock Forecast Amgen Hold 9
$226.87 Buy/Sell $246.51 12.40%
DE Stock Forecast Deere & Outperform 11
$332.24 Buy/Sell $402.13 22.20%

Bayer Dividend per Share Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Dividend per Share has decreased by 28.57%, going from 2.80€ to 2.00€. For next year, analysts predict Dividend per Share of 2.22€, which would mean an increase of 11.00%. Over the next nine years, experts predict that Bayer's Dividend per Share will grow at a rate of 20.00%.

2022 DPS Forecast
2.22€
2023 DPS Forecast
2.45€
2024 DPS Forecast
2.54€
2025 DPS Forecast
2.83€
2026 DPS Forecast
2.40€
2027 DPS Forecast
2.40€
2028 DPS Forecast
2.40€
2029 DPS Forecast
2.40€
2030 DPS Forecast
2.40€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CSL Stock Forecast CSL Outperform 16
$284.81 Buy/Sell $228.01 -22.67%
GILD Stock Forecast Gilead Sciences Outperform 11
$62.34 Buy/Sell $69.65 13.89%
BDX Stock Forecast Becton, Dickinson and Outperform 17
$231.64 Buy/Sell $278.08 20.88%

Bayer Free Cash Flow Forecast for 2022 - 2025 - 2030

Bayer's Free Cash Flow has decreased by 53.46% In the last three years, from 5.32€B to 2.48€B. In the next year, analysts believe that Free Cash Flow will reach 3.54€B – an increase of 42.91%. For the next nine years, experts predict that Bayer's Free Cash Flow will grow at a rate of 122.32%.

2022 FCF Forecast
3.54€B
2023 FCF Forecast
5.59€B
2024 FCF Forecast
6.35€B
2025 FCF Forecast
7.46€B
2026 FCF Forecast
7.32€B
2027 FCF Forecast
6.17€B
2028 FCF Forecast
5.73€B
2029 FCF Forecast
5.62€B
2030 FCF Forecast
5.51€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CL Stock Forecast Colgate-Palmolive Outperform 18
$75.00 Buy/Sell $82.26 9.33%
GSK Stock Forecast GSK Outperform 16
£13.25 Buy/Sell £16.08 43.02%
CTVA Stock Forecast Corteva Outperform 12
$57.61 Buy/Sell $62.59 21.51%

Bayer Net Income Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Net Income has decreased from 1.70€B to 1000.00€M – a 41.00% drop. In the next year, analysts believe that Net Income will reach 7.47€B – an increase of 646.84%. For the next nine years, the forecast is for Net Income to grow by 557.30%.

2022 NI Forecast
7.47€B
2023 NI Forecast
7.93€B
2024 NI Forecast
8.36€B
2025 NI Forecast
8.42€B
2026 NI Forecast
7.44€B
2027 NI Forecast
7.12€B
2028 NI Forecast
6.82€B
2029 NI Forecast
6.64€B
2030 NI Forecast
6.57€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAS Stock Forecast BASF Outperform 11
39.81€ Buy/Sell 78.27€ 38.16%
DOW Stock Forecast Dow Hold 11
$43.39 Buy/Sell $73.11 26.76%
BIIB Stock Forecast Biogen Outperform 11
$195.75 Buy/Sell $242.78 16.22%

Bayer EBITDA Forecast for 2022 - 2025 - 2030

Bayer's EBITDA has seen impressive growth In the last three years, rising from 7.15€B to 8.42€B – a growth of 17.89%. In the next year, analysts believe that EBITDA will reach 12.89€B – an increase of 53.04%. For the next nine years, the forecast is for EBITDA to grow by 137.66%.

2022 EBITDA Forecast
12.89€B
2023 EBITDA Forecast
13.29€B
2024 EBITDA Forecast
13.61€B
2025 EBITDA Forecast
13.65€B
2026 EBITDA Forecast
12.12€B
2027 EBITDA Forecast
14.47€B
2028 EBITDA Forecast
15.87€B
2029 EBITDA Forecast
17.86€B
2030 EBITDA Forecast
20.02€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAX Stock Forecast Baxter International Outperform 17
$54.91 Buy/Sell $69.92 25.66%
GIVN Stock Forecast Givaudan Hold 18
CHF2.95k Buy/Sell CHF4.11k 20.60%
DD Stock Forecast DuPont de Nemours Outperform 17
$50.05 Buy/Sell $76.56 47.85%

Bayer EBIT Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's EBIT has grown by 68.01%, rising from 4.26€B to 7.15€B. For the next year, analysts predict that EBIT will reach 8.46€B – an increase of 18.27%. Over the next nine years, experts believe that Bayer's EBIT will grow at a rate of 194.78%.

2022 EBIT Forecast
8.46€B
2023 EBIT Forecast
8.95€B
2024 EBIT Forecast
9.30€B
2025 EBIT Forecast
10.02€B
2026 EBIT Forecast
8.86€B
2027 EBIT Forecast
12.64€B
2028 EBIT Forecast
14.75€B
2029 EBIT Forecast
17.56€B
2030 EBIT Forecast
21.08€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.89k Buy/Sell ¥0.00 27.05%
ALNY Stock Forecast Alnylam Pharmaceuticals Outperform 7
$197.39 Buy/Sell $209.00 21.33%
BEI Stock Forecast Beiersdorf Outperform 17
101.00€ Buy/Sell 102.71€ 10.89%

Bayer EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's EPS has grown by 9.60%, rising from 5.94€ to 6.51€. For next year, analysts predict EPS of 7.61€, which would mean an increase of 16.90%. Over the next nine years, experts predict that Bayer's EPS will grow at a rate of 2.76%.

2022 EPS Forecast
7.61€
2023 EPS Forecast
8.11€
2024 EPS Forecast
8.52€
2025 EPS Forecast
8.88€
2026 EPS Forecast
8.61€
2027 EPS Forecast
7.25€
2028 EPS Forecast
6.94€
2029 EPS Forecast
6.77€
2030 EPS Forecast
6.69€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GMAB Stock Forecast Genmab A/S Outperform 16
kr2.45k Buy/Sell kr2.84k 12.11%
SGO Stock Forecast Compagnie de Saint-Gobain Outperform 18
37.49€ Buy/Sell 71.19€ 96.05%
CHD Stock Forecast Church & Dwight Hold 11
$75.26 Buy/Sell $90.41 18.39%